FHM Life Sciences VIII, L.P.
- SEC CIK
- 0001698755
No open-market purchases or sales filed in the past year.
Current role at each company
- ARQT Arcutis Biotherapeutics, Inc.10% Owneras of Oct 26, 2023
- ALPN Alpine Immune Sciences, Inc.10% Owneras of Feb 15, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists FHM Life Sciences VIII, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARQT Arcutis Biotherapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2023 (view filing)4:09 PM ET | Oct 24 | 2 days | Heron Patrick J and 4 othersDirector, 10% Owner | PPurchase | +80.0K | $2.50 | +$200.0K | +0.9%8.76M after | |
| Aug 9, 2022 (view filing)4:34 PM ET | Aug 5 | 4 days | Heron Patrick J and 4 othersDirector, 10% Owner | PPurchase | +250.0K | $20.00 | +$5.00M | +3.0%8.68M after |
ALPN Alpine Immune Sciences, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 (view filing)5:00 PM ET | Feb 11 | 4 days | Topper James N and 4 othersDirector, 10% Owner | PPurchase | +112.7K | $7.10 | +$800.0K | +8.2%1.48M after |